Sciele Pharma, Inc. (NASDAQ:SCRX), a specialty pharmaceutical company, announced that Edward J. Schutter, President and Chief Operating Officer, will make a presentation at the JPMorgan 26th Annual Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Wednesday, January 9, 2008, at 9:00 a.m. Pacific Time (see also Sciele Pharma, Inc.).
The audio presentation is being broadcast on the Internet and may be accessed at the Company's website, www.sciele.com.
Sciele Pharma, Inc. Background
Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Metabolic, Women's Health and Pediatrics. The Company's Cardiovascular/Metabolic products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, coughs and colds, and attention deficit/hyperactivity disorder (ADHD). Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma employs more than 900 people. The Company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity, and Teamwork.
Keywords: Sciele Pharma, Inc., Pediatric, Mental Health, Cardiology, Cardiovascular, Women's Health, Pharmaceuticals
This article was prepared by Health & Medicine Week editors from staff and other reports. Copyright 2008, Health & Medicine Week via NewsRx.com.
No comments:
Post a Comment